AAAAAA
Results:
1-18
|
Results: 18
Authors:
SCUDIERO DA
MONKS A
SAUSVILLE EA
Citation: Da. Scudiero et al., CELL-LINE DESIGNATION CHANGE - MULTIDRUG-RESISTANT CELL-LINE IN THE NCI ANTICANCER SCREEN, Journal of the National Cancer Institute, 90(11), 1998, pp. 862-862
Authors:
MONKS A
HOLLINGSHEAD M
SAUSVILLE EA
Citation: A. Monks et al., IDENTIFICATION OF NOVEL CHEMICAL CLASSES WITH POTENTIAL UTILITY AGAINST AIDS-RELATED LYMPHOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 85-85
Authors:
WOO ES
MONKS A
WATKINS SC
WANG AS
LAZO JS
Citation: Es. Woo et al., DIVERSITY OF METALLOTHIONEIN CONTENT AND SUBCELLULAR-LOCALIZATION IN THE NATIONAL-CANCER-INSTITUTE TUMOR PANEL, Cancer chemotherapy and pharmacology, 41(1), 1997, pp. 61-68
Authors:
ZHAN AR
SCALA S
MONKS A
HOSE C
BATES S
FOJO T
Citation: Ar. Zhan et al., RESISTANCE TO PACLITAXEL MEDIATED BY P-GLYCOPROTEIN CAN BE MODULATED BY CHANGES IN THE SCHEDULE OF ADMINISTRATION, Cancer chemotherapy and pharmacology, 40(3), 1997, pp. 245-250
Authors:
MONKS A
SCUDIERO DA
JOHNSON GS
PAULL KD
SAUSVILLE EA
Citation: A. Monks et al., THE NCI ANTICANCER DRUG SCREEN - A SMART SCREEN TO IDENTIFY EFFECTORSOF NOVEL TARGETS, Anti-cancer drug design, 12(7), 1997, pp. 533-541
Authors:
OCONNOR PM
JACKMAN J
BAE I
MYERS TG
FAN SJ
MUTOH M
SCUDIERO DA
MONKS A
SAUSVILLE EA
WEINSTEIN JN
FRIEND S
FORNACE AJ
KOHN KW
Citation: Pm. Oconnor et al., CHARACTERIZATION OF THE P53 TUMOR-SUPPRESSOR PATHWAY IN CELL-LINES OFTHE NATIONAL-CANCER-INSTITUTE ANTICANCER DRUG SCREEN AND CORRELATIONSWITH THE GROWTH-INHIBITORY POTENCY OF 123 ANTICANCER AGENTS, Cancer research, 57(19), 1997, pp. 4285-4300
Authors:
BATES SE
WILSON WH
FOJO AT
ALVAREZ M
ZHAN Z
REGIS J
ROBEY R
HOSE C
MONKS A
KANG YK
CHABNER B
Citation: Se. Bates et al., CLINICAL REVERSAL OF MULTIDRUG-RESISTANCE, Stem cells, 14(1), 1996, pp. 56-63
Authors:
CYSYK RL
CHISENA CA
HYMAN R
MONKS A
Citation: Rl. Cysyk et al., TIAZOFURIN ENHANCES THE ANABOLISM AND TOXICITY OF 5-FLUOROURACIL, Cancer letters, 109(1-2), 1996, pp. 49-55
Authors:
TEW KD
MONKS A
BARONE L
ROSSER D
AKERMAN G
MONTALI JA
WHEATLEY JB
SCHMIDT DE
Citation: Kd. Tew et al., GLUTATHIONE-ASSOCIATED ENZYMES IN THE HUMAN CELL-LINES OF THE NATIONAL-CANCER-INSTITUTE DRUG SCREENING-PROGRAM, Molecular pharmacology, 50(1), 1996, pp. 149-159
Authors:
KOO HM
MONKS A
MIKHEEV A
RUBINSTEIN LV
GRAYGOODRICH M
MCWILLIAMS MJ
ALVORD WG
OIE HK
GAZDAR AF
PAULL KD
ZARBL H
VANDEWOUDE GF
Citation: Hm. Koo et al., ENHANCED SENSITIVITY TO 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND TOPOISOMERASE-II INHIBITORS IN TUMOR-CELL LINES HARBORING ACTIVATED RAS ONCOGENES, Cancer research, 56(22), 1996, pp. 5211-5216
Authors:
ALVAREZ M
PAULL K
MONKS A
HOSE C
LEE JS
WEINSTEIN J
GREVER M
BATES S
FOJO T
Citation: M. Alvarez et al., GENERATION OF A DRUG-RESISTANCE PROFILE BY QUANTITATION OF MDR-1 P-GLYCOPROTEIN IN THE CELL-LINES OF THE NATIONAL-CANCER-INSTITUTE ANTICANCER DRUG SCREEN/, The Journal of clinical investigation, 95(5), 1995, pp. 2205-2214
Authors:
KOO HM
MONKS A
MIKHEEV A
RUBINSTEIN LV
GRAYGOODRICH M
MCWILLIAMS MJ
OIE HK
GAZDAR AF
PAULL KD
ZARBL H
VANDEWOUDE GF
Citation: Hm. Koo et al., ENHANCED SENSITIVITY TO CYTOSINE-ARABINOSIDE AND TOPOISOMERASE-II INHIBITORS IN TUMOR-CELL LINES HARBORING MUTATIONS IN RAS ONCOGENES, Blood, 86(10), 1995, pp. 2037-2037
Authors:
CLEAVELAND ES
MONKS A
VAIGROWOLFF A
ZAHAREVITZ DW
PAULL K
ARDALAN K
COONEY DA
FORD H
Citation: Es. Cleaveland et al., SITE OF ACTION OF 2 NOVEL PYRIMIDINE BIOSYNTHESIS INHIBITORS ACCURATELY PREDICTED BY THE COMPARE PROGRAM, Biochemical pharmacology, 49(7), 1995, pp. 947-954
Authors:
WEINSTEIN JN
MYERS T
BUOLAMWINI J
RAGHAVAN K
VANOSDOL W
LICHT J
VISWANADHAN VN
KOHN KW
RUBINSTEIN LV
KOUTSOUKOS AD
MONKS A
SCUDIERO DA
ANDERSON NL
ZAHAREVITZ D
CHABNER BA
GREVER MR
PAULL KD
Citation: Jn. Weinstein et al., PREDICTIVE STATISTICS AND ARTIFICIAL-INTELLIGENCE IN THE TITUTES-DRUG-DISCOVERY-PROGRAM-FOR-CANCER-AND-AIDS, Stem cells, 12(1), 1994, pp. 13-22
Authors:
PETERS AC
SMYTHE AM
WU L
MONKS A
BOYD MR
SHOEMAKER RH
Citation: Ac. Peters et al., LEVELS OF MESSENGER-RNA CODING FOR DNA TOPOISOMERASE-II ISOFORMS DO NOT CORRELATE WITH IN-VITRO DRUG-SENSITIVITY, Oncology Reports, 1(5), 1994, pp. 907-911
Authors:
RYBAK SM
LIN JJ
NEWTON DL
KUNG HF
MONKS A
CHEN HC
HUANG PL
LEEHUANG S
Citation: Sm. Rybak et al., IN-VITRO ANTITUMOR-ACTIVITY OF THE PLANT RIBOSOME-INACTIVATING PROTEINS MAP-30 AND GAP-31, International journal of oncology, 5(5), 1994, pp. 1171-1176
Authors:
LEE JS
PAULL K
ALVAREZ M
HOSE C
MONKS A
GREVER M
FOJO AT
BATES SE
Citation: Js. Lee et al., RHODAMINE EFFLUX PATTERNS PREDICT P-GLYCOPROTEIN SUBSTRATES IN THE NATIONAL-CANCER-INSTITUTE DRUG SCREEN, Molecular pharmacology, 46(4), 1994, pp. 627-638
Authors:
GHAREHBAGHI K
PAULL KD
KELLEY JA
BARCHI JJ
MARQUEZ VE
COONEY DA
MONKS A
SCUDIERO D
KROHN K
JAYARAM HN
Citation: K. Gharehbaghi et al., CYTOTOXICITY AND CHARACTERIZATION OF AN ACTIVE METABOLITE OF BENZAMIDE RIBOSIDE, A NOVEL INHIBITOR OF IMP DEHYDROGENASE, International journal of cancer, 56(6), 1994, pp. 892-899
Risultati:
1-18
|